Smaller very low density lipoprotein (VLDL) remnants interact more readily with tissues than do larger "intact" VLDL. This may be related to changes in the availability of VLDL apoproteins on the surface of the lipoproteins. To test this hypothesis VLDL were incubated at 37°C with bovine milk lipase (LPL), and the abilities of LPL-treated VLDL preparations to compete with 125 I-low density lipoproteins (LDL) for interaction with cultured normal human fibroblasts were measured. At the same time, the immunologic activities of these preparations were also tested by double antibody radioimmunoassay. Triglyceride (TG) contents of VLDL fell by 30-90% during incubation with LPL and, on zonal ultracentrifugation, VLDL of faster Svedberg unit of flotation (S f1.063 ) rates (>150) were gradually converted to smaller VLDL with lower S f rates (21-60). LPL-treated VLDL competed two to five times more effectively with 125 I-LDL for binding to cellular receptors than did control VLDL. Control VLDL incubated with heat-inactivated LPL at 37°C, or with active LPL at 4°C had unaltered cell reactivities and TG contents compared with VLDL incubated without any enzyme. The direct uptake and degradation of LPL-treated VLDL was also assessed by using VLDL 125 I-labeled in apoprotein (Apo)B. LPL-treated VLDL-125 IApoB were taken up and degraded by fibroblast at greater rates than were control VLDL-125 I-ApoB. Thus, hydrolysis of VLDL lipids was accompanied by an increased ability of […] 1288 between LPL-treated and control VLDL. Thus, VLDL lipid hydrolysis was accompanied by changes in the immunoreactivity of VLDL-ApoB, which probably reflect changes in the disposition of ApoB on the surface of VLDL. The altered disposition of ApoB on VLDL "remnants" may be related to their enhanced interaction with cells.
INTRODUCTION
Very low density lipoproteins (VLDL)1 are secreted by the liver as spherical particles that consist of lipids and apoproteins, and chylomicrons and VLDL are secreted by the gut (1, 2) . Upon entering the plasma compartment, these triglyceride (TG)-rich particles undergo a series of transformations by means of which they are converted progressively to smaller particles-called intermediate density lipoproteins or remnants-and finally to low density lipoproteins (LDL) (3, 4) . During catabolism there are net losses of both core and surface components, e.g., TG and phospholipids, respectively (5, 6) . Apoproteins (Apo)C and E too are lost, but ApoB remains with the remnants.
VLDL remnants are taken up more rapidly by cells in culture than are large VLDL particles (7) , and chylomicron remnants are removed much more rapidly from the circulation by liver in vivo (8, 9) and in vitro (10, 11) than are chylomicrons. Thus, partial lipolysis of the TG-rich lipoproteins appears to be necessary for their efficient uptake by cells. This is true for both human and animal lipoproteins (12) .
The uptake of human and animal LDL by fibroblasts and other cells occurs by adsorptive endocytosis via a specific LDL receptor that is located in coated pits on the surfaces of cells (13) . The LDL receptor recognizes two apoproteins-ApoB (14, 15) and ApoE (16)-both of which are contained on VLDL and chylomicrons isolated from human plasma (17) . Human LDL (d 1.025-1.050) contain only ApoB (18) . The enhanced reactivity of remnants with cells could be a result of several changes which accompany remnant formation: (a) As larger lipoproteins are converted to smaller remnants, steric hindrance to their interactions with cellular receptors could be reduced. (b) The selective retention of ApoB in remnants could "concentrate" ApoB over the surfaces of the lipoproteins. (c) The conformations of binding sites of apoproteins could be altered as the surface areas of the lipoproteins are reduced. (d) Binding sites on apoproteins could be unmasked as a consequence of the removal of lipids or proteins from lipoprotein surfaces. It is difficult, by techniques available at this time, to distinguish among all of these possibilities. However, immunologic techniques do allow one to assess the immunoreactivities of individual lipoprotein-associated apoproteins (19) , and to ascertain whether the immunologically active regions on apoprotein molecules are altered during lipoprotein catabolism. At the same time, the interactions of the lipoproteins with cellular receptors can be assessed. The aim of this work was to ascertain whether the immunoreactivity of ApoB, a major protein in VLDL, was altered during the course of VLDL lipid hydrolysis and to assess whether this immunologic change coincided with any alterations in the ability of VLDL to interact with the LDL receptor on cells.
METHODS
VLDL were isolated from plasma by ultracentrifugation in swinging bucket (SW40, SW27) or zonal (Ti 14) rotors in a Beckman L265B ultracentrifuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.) in salt gradients (20, 21) . Svedberg unit of flotation (Sf) > 100 fractions from swinging buckets and Sf > 150 fractions from zonal rotors were used as starting materials for bovine milk lipase (LPL) digestions. Swinging bucket fractions were purified by column filtration as follows: 1-ml VLDL aliquots, containing -2-3 mg ofVLDL protein, were filtered on 0.7 x 40-or 60-cm columns of Sepharose 2B (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) (1 mM EDTA, 0.16 M NaCl, pH 7.4). VLDL eluted in the first peak (280 nm). Zonal fractions were purified by recentrifugation in the zonal rotor under the same conditions used for the original isolations.
To produce VLDL remnants, aliquots of VLDL (-0.5 ing protein/ml) were incubated at 37°C in Krebs-Ringer bicarbonate, pH 7.4, or in 0.2 NI Tris HCI, pH 8.2. Both buffers contained 10% bovine serum albumin (Fraction V, Fatty Acid Free, Miles Laboratories, Inc., Elkhart, Ind.). Bovine milk lipoprotein lipase (prepared by heparin-Sepharose 4B affinity chromatography [22] , specific activity: ,umol FFA/h per ml) was added, and incubations were carried out for up to 10 h. Control VLDL were incubated at 4°C with active LPL, at 37°C in the presence of inactivated LPL (50°C for 1 h or 23°C for 24 h), or at 37°C in the absence of LPL. All of these controls gave identical results. At the end of incubation, tuibes were placed on ice, and samples were taken for determination of levels of ApoB and TG, and for incubation with cultured human fibroblasts. In selected instances, LPL-treated VLDL and control VLDL were refiltered on the Sepharose columns or subjected to zonal ultracentrifugation. These fractions were analyzed for their contents of apoproteins and lipids and also incubated with cells.
TG and cholesterol (Chol) analyses were perfonred on chloroform-methanol extracts (23) . Aliquots of organic phase, which had been "washed" with 0.15 M NaCl, were dried under N2, redissolved in isopropanol, and, after addition of zeolite, processed on an AutoAnalyzer II (Technicon Instruments Corp., Tarrytown, N. Y.) (24) . TG, free, and esterified Chol were also determined enzymatically (25, 26) (32, 33) . ApoB was in peak 1 (18) . The ApoB content of VLDL fractioins was also assessed by the method of Kane et al. (34, 35) using tetramethyl urea (TMU). AntiApoE antisera were produced against peak 2 of the Sephadex G200 columiin which had been repurified on the same column. ApoE migrated as a single band of -35,000 mol wt on sodiumll dodecyl sulfate gel electrophoresis (36) . Anti- rabbit IgG was produced in goats.
Normal fibroblasts were derived from skin explants taken from a 3-mo-old male, a 33-yr-old male, and a 40-yr-old female.
All normal lines gave similar results. Cell culture was as described by Goldstein and Brown (37) and Ostlunid et al. (38) . Fibroblasts were grown for 6 d in 2 ml of Eagle's minimum essential medium (Gibco Diagnostics, Chagrin Falls, Ohio) that contained 50 ,ug/ml streptomycin, 50 U/ml penicillini, 1.24 ,tg/ml amphotericin B (Fungizone, E. R. Squibb & Sons, Princeton, N. J.), and 15% fetal bovine serum (Gibco Diagnostics). The medium was then changed to 1 ml of Eagle's mnedium that contained antibiotics and 2.5 mg/ml human lipoprotein-deficient serum (LPDS), for 24 h before any experiment.
At the beginning of experiments, the LPDS-containing mediumn was removed, and each 35-mm dish received 1 ml of fresh medium (LPDS) that containied 5 ,ug/ml 1251-LDL iodinated with iodine monochloride to specific radioactivity -100 cpm/ng (39, 40) and the appropriate control or LPLtreated VLDL preparation. In one experiment, 5 jig/ml VLDL-'25I-ApoB was added directly. The cells were incubated at 40 or 37°C for 4 h, after which the experiment was termiinlated by removal of the medium and placement of the dishes on ice. The cells were washed (38) and dissolved in 1 ml of 0.1 N NaOH for determination of cell-accumulated 1251-LDL. At 40C, these cell-associated counts represent 1251-LDL bound to the cell receptors; at 37°C, the counts represent both cellreceptor bound and intracellular 1251-LDL. 1251-LDL degradation products, soluble in 10% TCA, were determined in the removed culture medium (37, 38 Table I ). In the swinging bucket Sf > 100 VLDL preparation, -20% of the TG was hydrolyzed in 15 min and -90% in 2 h (not shown). In the zonal rotor Sf > 150 preparation ( Fig. 1) , 7, 42, 76, and 89% of TG were hydrolyzed at 15, 90, 240, and 600 min, respectively.
LPL treatment of VLDL resulted in the production of materials with markedly changed Sf rates (Fig. 2) . As TG hydrolysis progressed, the Sf rate of the starting VLDL population dropped from Sf > 150 (peak a, zero time) to Sf > 130 (peak b, 90 min) and to Sf > 95 (peak d, 240 min). A second population of VLDL also appeared.
At 90 min (peak c) this peak had Sf rate of -75 and at 240 min an Sf rate of -50 (peak e). By the end of incubation (600 min), the faster floating VLDL had disappeared and all ofthe VLDL was found in the Sf 21-60 range (peakf). These determinations of Sf rates were carried out under rate zonal conditions. It was also possible to demonstrate under equilibrium conditions that the density of VLDL was altered by LPL treatment. Whereas -90% of the control VLDL-251-ApoB (see Fig. 6 ) floated in the top 1 ml ofthe tube after ultracentrifugation at d 1.006 for 20 h in a 65 rotor, only 2% of the LPL-treated VLDL-1251-ApoB floated at d 1.006 under identical conditions. The apparent Stokes radii of VLDL were also reduced by LPL treatment, i.e., on column chromatography the lipolyzed VLDL was more retarded on the column than was the starting material (not shown). Lipolysis produced marked alterations in VLDL compositions. For example (Fig. 2) Table I . Each of the VLDL preparations was assayed with one or more anti-LDL and one or more anti-ApoB antisera. In each case, when analyzed with the anti-LDL antiserum (R71, R124, R198), the LPL-treated VLDL appeared to contain more ApoB than did the non-LPL or the inactive LPL control VLDL, whereas the assays that contained anti-ApoB antisera (R83, R161, or R162) were not able to distinguish between the LPL-treated and control VLDL. Antiserum R161 appeared to detect more ApoB in the VLDL preparations than did other antisera.
It should be noted that these immunologic changes were not a result of any proteolytic activity of LPL (41) . '25I-LDL was incubated with or without LPL at 37°C for 2 h. 85-87% of the 1251 counts were precipitable by 10% TCA in the LPL and 86% in the control incubations, respectively. The specificities of the radio immunoassays for ApoB should also be noted. The antiAltered Apoprotein B Immunoreactivity (Table II) isolated by density-gradient ultracentrifugation in an SW41 rotor were used in these experiments. VLDL protein was determined by the method of Lowry et al. (29) . ApoB contents were measured by radioimmunoassay (RIA) using the antisera as described in Table I the VLDL with cells. The column-filtered, LPL-treated VLDL was four times more effective than the columnfiltered control VLDL in competing with 1251-LDL for cellular binding, uptake, and degradation. The cell surface binding properties of the VLDL lipolysis products isolated by zonal ultracentrifugation (Fig. 2) were tested in competitive assays carried out at 4°C (Fig. 5) . Binding was inversely related to Sf rate (and size), even when expressed on the basis of TMUinsoluble protein. There was a direct relationship between the competitiveness of the VLDL fractions vs. 1251-LDL, for bindng to the LDL receptors on the one hand and for binding to anti-ApoB antibodies on the other (compare Figs. 1 and 5) .
The direct uptake and degradation of LPL-treated VLDL by cultured fibroblasts was evaluated next (Fig.  6) . VLDL was isolated by ultracentrifugation at d 1.006, iodinated with '25I-C1 (39, 40) , and incubated with unlabeled high density lipoprotein (HDL) (d 1.063-1.19) for 2 h at 37-C to dilute out any ApoC which had become labeled in VLDL by exchange with the "cold" 4 The effects of lipolysis of VLDL on its ability to compete with 1251-LDL for uptake and degradation by human fibroblasts. LPL-treated or control aliquots of preparation "d" of Table I or "9,cold" LDL were added to fibroblast cultures that had been grown in lipoprotein-deficient medium for 24 h. 5 Ag/ml of 125I-LDL (87 cpm/ng) was also present in the media. The cell-associated 125I-LDL counts were determined 2 h later. These contain counts bound to the surface and internalized by the cells. The VLDL-ApoB curve gives the results for the control VLDL when the VLDL added to the cultures is quantified in terms of its contents of ApoB, rather than its total protein.
ratio during this incubation was 50:1. At the end of incubation, the VLDL-HDL mixture was ultracentrifuged at d 1.006 for 108 g/min in a 40.3 Beckman rotor. VLDL was removed by pipetting. 87% of the 1251-label in this preparation was precipitable by TMU and 8% was in lipid, which suggested that virtually all of the protein label was in ApoB. The 125I-VLDL was split into two aliquots, one aliquot was incubated without LPL and the other with LPL for 2 h at 37°C. After incubation, VLDL was reisolated by column chromatography on Sepharose 2B as described above. The specific radioactivity of the '251-ApoB in VLDL (Fig. 6) , the LPL-treated preparation was taken up and degraded at a much greater rate than was the control preparation.
Finally, competitive binding assays were carried out at 4°C using the zonal subfractions of VLDL isolated from plasma (Table IV) , which were incubated with cultured fibroblasts, and 125I-LDL (Fig. 7) . Here too, as in the case of the LPL-treated VLDL (Figs. 2 and 5 ), the competitiveness of the VLDL subfractions was inversely related to their Sf rates, and again there were strong relationships between the ApoB immunoreactivities and the cell reactivities of VLDL preparations (Table IV, Figs. 3 and 7) . Those fractions which competed most effectively with 125I-LDL for limiting amounts of anti-ApoB antibodies also competed most effectively with 125I-LDL for cellular LDL receptors.
DISCUSSION
Partially catabolized TG-rich lipoproteins are more effectively removed by arterial smooth muscle cells, fibroblasts, and liver than are more "intact" lipoproteins (7) (8) (9) (10) (11) (12) . LPL, the enzyme responsible for the lipolysis of these particles, produces particles which are smaller in size, depleted in TG, and relatively rich in Chol esters, PL, and ApoB (3) (4) (5) (6) . We (Table IV) were incubated at 40C with normal fibroblasts as in Fig. 5 The fact that some antisera were and others were not able to detect changes in ApoB immunoreactivity is interpreted as being because of the fact that antiApoB and anti-LDL antisera contained populations of antibodies with different ranges of specificities vs. ApoB. This is not too surprising because isolated ApoB and the ApoB in holo-LDL, both of which were used on the production of antisera, need not be identical immunogens. Analogous differences in antiserum specificity have been reported for antisera produced against isolated ApoA-I and HDL-associated ApoA-I (43, 44) .
The altered immunoreactivity of ApoB was not a result of changes in VLDL size (i.e., steric hindrance) alone because whereas some antisera were able to detect differences between control VLDL and LPLtreated VLDL, others were unable to do so. Had size alone been the crucial factor, all antisera should have yielded similar results. The change in immunoreactivity also did not appear to be a result of proteolysis. The remaining possibilities are that as lipids and apoproteins were removed during lipolysis, "masked" areas of ApoB became uncovered, or that, as the larger VLDL spheres were converted to smaller spheres, the concentrations, conformation, or dispositions of ApoB on the surfaces of the particles were altered to adjust to the new surface geometry and composition of the particles. It is likely that several ofthese events were occurring simultaneously. Compatible conclusions were reached by Gianturco et Alterations in the immunoreactivity ofApoE, another protein recognized by cells, were not found. This does not exclude the existence of LPL-induced changes in ApoE because only two anti-ApoE antisera were used. Perhaps other antisera directed against VLDL-associated ApoE could have detected some differences. However, it should be noted that in contrast with ApoB, which became "concentrated" on the smaller particles, the ApoE contents of the slower floating smaller fractions were less than those of the faster, larger fractions. Thus, the ApoE concentration at the surfaces of the particles should be considerably less than the surface concentrations of ApoB.
The changes in ApoB immunoreactivity were accompanied by striking increases in the abilities of LPL-treated particles to compete with 125I-LDL for binding, uptake, and degradation by fibroblasts. Those fractions that competed most effectively with 1251-LDL for binding to anti-ApoB antibody also competed most effectively with 125I-LDL for binding to cellular LDLreceptors. In addition, LPL-treated VLDL-251-ApoB was taken up and degraded much more avidly than were the control preparations. Although we have not ruled out the effects of other apoproteins (e.g., ApoE), the coincidence of changes in the immunoreactivity of VLDL-ApoB and the enhanced recognition of VLDL by cells suggests that the lipolysis-induced alterations in the disposition of ApoB on the surfaces of VLDL may be related to the enhanced interactions of the partially degraded VLDL with cells.
